title: Recent advances in cardiovascular proteomics.
abstract: Cardiovascular diseases (CVDs) are the major source of global morbidity and death and more people die annually from CVDs than from any other cause. These diseases can occur quickly, as seen in acute myocardial infarction (AMI), or progress slowly over years as with chronic heart failure. Advances in mass spectrometry detection and analysis, together with improved isolation and enrichment techniques allowing for the separation of organelles and membrane proteins, now allow for the indepth analysis of the cardiac proteome. Here we outline current insights that have been provided through cardiovascular proteomics, and discuss studies that have developed innovative technologies which permit the examination of the protein complement in specific organelles including exosomes and secreted proteins. We highlight these foundational studies and illustrate how they are providing the technologies and tools which are now being applied to further study cardiovascular disease; provide new diagnostic markers and potentially new methods of cardiac patient management with identification of novel drug targets. This article is part of a Special Issue entitled: From protein structures to clinical applications.
authors.affiliation: Department of Physiology, University of Toronto, Toronto, Ontario, Canada M5G 1L6. parveen.sharma@utoronto.ca
authors.forename: Parveen
authors.initials: P
authors.lastname: Sharma
authors.forename: Jake
authors.initials: J
authors.lastname: Cosme
authors.forename: Anthony O
authors.initials: AO
authors.lastname: Gramolini
mesh_terms: D000818:Animals; D006801:Humans; D009124:Muscle Proteins / Q000378:metabolism*; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D020543:Proteome / Q000378:metabolism*; D040901:Proteomics / Q000295:instrumentation / Q000379:methods*
chemical_list: D009124:Muscle Proteins; D020543:Proteome